FDA Issues Guidance on Using EHR Data in Clinical Studies
The Food and Drug Administration this week issued guidance intended to clarify the agency’s expectations when electronic health records are used as a source of data in clinical investigations. The guidance applies to clinical investigations of human drugs and biological products, medical devices and combination products, including investigations conducted in clinical practice settings.
Related News Articles
Headline
In a letter to the Centers for Medicare & Medicaid Services and Office of the National Coordinator for Health Information Technology, AHA Jan. 2 expressed…
Chairperson's File
Nearly 15 years ago, a study published in the New England Journal of Medicine estimated that only 1.5% of acute care general medical and surgical hospitals had…
Headline
Medicare eligible hospitals and critical access hospitals must attest to meaningful use of electronic health records for the 2021 Promoting Interoperability…
Headline
The Office of the National Coordinator for Health Information Technology Sept. 14 at 1 p.m. ET will host a webinar focused on its information blocking…
Headline
The Department of Health and Human Services today finalized its strategy to reduce regulatory and administrative burdens for health care providers using…
Headline
Less than 1% of the net electronic health record incentive payments Medicare paid to acute-care hospitals between Jan. 1, 2013 and Sept. 30, 2017 did not meet…